Listed

Bio Green Med Solution, Inc.

BGMSNasdaqCIK 1130166Consumer discretionaryFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$336.0k, Q2 FY2026
Operating income−$418.0k, Q2 FY2026
Net income−$405.0k, Q2 FY2026
Bio Green Med Solution, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k16.0Revenue, Q3 FY2023, three months to 2023-09-30$16.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure31.0Revenue, Q4 FY2023, three months to 2023-12-31$31.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K/A filed 2025-11-26, accession 0001493152-25-025179. Derived: 12-month figure less the 9-month figure.Report this figure29.0Revenue, Q1 FY2024, three months to 2024-03-31$29.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure4.0Revenue, Q2 FY2024, three months to 2024-06-30$4.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure10.0Revenue, Q3 FY2024, three months to 2024-09-30$10.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported81.0Revenue, Q3 FY2025, three months to 2025-09-30$81.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure(81.0)Revenue, Q4 FY2025, three months to 2025-12-31−$81.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figure743Revenue, Q1 FY2026, three months to 2026-03-31$743.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure336Revenue, Q2 FY2026, three months to 2026-06-30$336.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure
Cost of revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k5,236Research and development, Q3 FY2023, three months to 2023-09-30$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure3,518Research and development, Q4 FY2023, three months to 2023-12-31$3.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2025-11-26, accession 0001493152-25-025179. Derived: 12-month figure less the 9-month figure.Report this figure2,802Research and development, Q1 FY2024, three months to 2024-03-31$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure2,023Research and development, Q2 FY2024, three months to 2024-06-30$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure950Research and development, Q3 FY2024, three months to 2024-09-30$950.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure880Research and development, Q4 FY2024, three months to 2024-12-31$880.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figure822Research and development, Q1 FY2025, three months to 2025-03-31$822.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure68.0Research and development, Q2 FY2025, three months to 2025-06-30$68.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure5.0Research and development, Q3 FY2025, three months to 2025-09-30$5.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure(47.0)Research and development, Q4 FY2025, three months to 2025-12-31−$47.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Selling, general and administrative$k1,625Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure1,873Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-04-02, accession 0001558370-25-004331. Derived: 12-month figure less the 9-month figure.Report this figure1,582Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-05-14, accession 0001558370-24-008159.Report this figure1,625Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-08-14, accession 0001558370-24-012271.Report this figure1,237Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure948Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$948.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-04-02, accession 0001558370-25-004331. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Operating income$k(6,845)Operating income, Q3 FY2023, three months to 2023-09-30−$6.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure(5,360)Operating income, Q4 FY2023, three months to 2023-12-31−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2025-11-26, accession 0001493152-25-025179. Derived: 12-month figure less the 9-month figure.Report this figure(4,355)Operating income, Q1 FY2024, three months to 2024-03-31−$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure(3,644)Operating income, Q2 FY2024, three months to 2024-06-30−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure(2,177)Operating income, Q3 FY2024, three months to 2024-09-30−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure(1,828)Operating income, Q4 FY2024, three months to 2024-12-31−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figure(4,214)Operating income, Q1 FY2025, three months to 2025-03-31−$4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure(1,249)Operating income, Q2 FY2025, three months to 2025-06-30−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure(992)Operating income, Q3 FY2025, three months to 2025-09-30−$992.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure(1,082)Operating income, Q4 FY2025, three months to 2025-12-31−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figure(246)Operating income, Q1 FY2026, three months to 2026-03-31−$246.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure(418)Operating income, Q2 FY2026, three months to 2026-06-30−$418.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$k(668)Income tax, Q3 FY2023, three months to 2023-09-30−$668.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure(422)Income tax, Q4 FY2023, three months to 2023-12-31−$422.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K/A filed 2025-11-26, accession 0001493152-25-025179. Derived: 12-month figure less the 9-month figure.Report this figure(1,354)Income tax, Q1 FY2024, three months to 2024-03-31−$1.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure(412)Income tax, Q2 FY2024, three months to 2024-06-30−$412.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure(210)Income tax, Q3 FY2024, three months to 2024-09-30−$210.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure1,194Income tax, Q4 FY2024, three months to 2024-12-31$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figurenot reported2.0Income tax, Q2 FY2025, three months to 2025-06-30$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001493152-25-022388. Derived: 9-month figure less the 6-month figure.Report this figure5.0Income tax, Q4 FY2025, three months to 2025-12-31$5.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figure30.0Income tax, Q1 FY2026, three months to 2026-03-31$30.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure9.0Income tax, Q2 FY2026, three months to 2026-06-30$9.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure
Net income$k(6,032)Net income, Q3 FY2023, three months to 2023-09-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure(5,271)Net income, Q4 FY2023, three months to 2023-12-31−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2025-11-26, accession 0001493152-25-025179. Derived: 12-month figure less the 9-month figure.Report this figure(2,946)Net income, Q1 FY2024, three months to 2024-03-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure(3,257)Net income, Q2 FY2024, three months to 2024-06-30−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure(1,957)Net income, Q3 FY2024, three months to 2024-09-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure(3,052)Net income, Q4 FY2024, three months to 2024-12-31−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figure(81.0)Net income, Q1 FY2025, three months to 2025-03-31−$81.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure(1,318)Net income, Q2 FY2025, three months to 2025-06-30−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure(988)Net income, Q3 FY2025, three months to 2025-09-30−$988.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure(611)Net income, Q4 FY2025, three months to 2025-12-31−$611.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figure(197)Net income, Q1 FY2026, three months to 2026-03-31−$197.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure(405)Net income, Q2 FY2026, three months to 2026-06-30−$405.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure
Diluted EPS$ per sharenot reportednot reported(2.27)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$2.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure(172.18)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$172.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure(43.80)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$43.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figurenot reported0.00Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure(0.98)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure(1.31)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figurenot reportednot reportednot reported
Basic EPS$ per sharenot reportednot reported(2.27)Basic EPS, Q1 FY2024, three months to 2024-03-31−$2.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure(172.18)Basic EPS, Q2 FY2024, three months to 2024-06-30−$172.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure(43.80)Basic EPS, Q3 FY2024, three months to 2024-09-30−$43.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figurenot reported0.00Basic EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure(0.98)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure(1.31)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figurenot reportednot reportednot reported

Balance sheet

Cash and equivalents$3.8m, Q2 FY2026
Shareholders' equity$7.2m, Q2 FY2026
Bio Green Med Solution, Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31period not labelled2024-03-11Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$k3,378Cash and equivalents, FY2023, at 2023-12-31$3.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K/A filed 2025-11-26, accession 0001493152-25-025179.Report this figure3,400Cash and equivalents, period not labelled, at 2024-03-11$3.4m. XBRL concept us-gaap:Cash. 10-K filed 2024-03-21, accession 0001558370-24-003713.Report this figure2,798Cash and equivalents, Q1 FY2024, at 2024-03-31$2.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001558370-24-008159.Report this figure6,000Cash and equivalents, Q2 FY2024, at 2024-06-30$6.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001558370-24-012271.Report this figure2,982Cash and equivalents, Q3 FY2024, at 2024-09-30$3.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure3,137Cash and equivalents, FY2024, at 2024-12-31$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001493152-26-013669.Report this figure3,450Cash and equivalents, Q1 FY2025, at 2025-03-31$3.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure4,275Cash and equivalents, Q2 FY2025, at 2025-06-30$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure3,838Cash and equivalents, Q3 FY2025, at 2025-09-30$3.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure3,505Cash and equivalents, FY2025, at 2025-12-31$3.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure3,339Cash and equivalents, Q1 FY2026, at 2026-03-31$3.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure3,790Cash and equivalents, Q2 FY2026, at 2026-06-30$3.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure
Current assets$k7,444Current assets, FY2023, at 2023-12-31$7.4m. XBRL concept us-gaap:AssetsCurrent. 10-K/A filed 2025-11-26, accession 0001493152-25-025179.Report this figurenot reported4,835Current assets, Q1 FY2024, at 2024-03-31$4.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008159.Report this figure7,707Current assets, Q2 FY2024, at 2024-06-30$7.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001558370-24-012271.Report this figure4,913Current assets, Q3 FY2024, at 2024-09-30$4.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure3,674Current assets, FY2024, at 2024-12-31$3.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001493152-26-013669.Report this figure3,714Current assets, Q1 FY2025, at 2025-03-31$3.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure4,383Current assets, Q2 FY2025, at 2025-06-30$4.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure6,444Current assets, Q3 FY2025, at 2025-09-30$6.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure6,256Current assets, FY2025, at 2025-12-31$6.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure5,622Current assets, Q1 FY2026, at 2026-03-31$5.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure5,969Current assets, Q2 FY2026, at 2026-06-30$6.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure
Total assets$k8,805Total assets, FY2023, at 2023-12-31$8.8m. XBRL concept us-gaap:Assets. 10-K/A filed 2025-11-26, accession 0001493152-25-025179.Report this figurenot reported6,165Total assets, Q1 FY2024, at 2024-03-31$6.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001558370-24-008159.Report this figure8,190Total assets, Q2 FY2024, at 2024-06-30$8.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001558370-24-012271.Report this figure5,381Total assets, Q3 FY2024, at 2024-09-30$5.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure4,094Total assets, FY2024, at 2024-12-31$4.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001493152-26-013669.Report this figure3,734Total assets, Q1 FY2025, at 2025-03-31$3.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure4,401Total assets, Q2 FY2025, at 2025-06-30$4.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure8,158Total assets, Q3 FY2025, at 2025-09-30$8.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure8,185Total assets, FY2025, at 2025-12-31$8.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure7,564Total assets, Q1 FY2026, at 2026-03-31$7.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure7,854Total assets, Q2 FY2026, at 2026-06-30$7.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure
Current liabilities$k8,161Current liabilities, FY2023, at 2023-12-31$8.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K/A filed 2025-11-26, accession 0001493152-25-025179.Report this figurenot reported8,350Current liabilities, Q1 FY2024, at 2024-03-31$8.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001558370-24-008159.Report this figure7,186Current liabilities, Q2 FY2024, at 2024-06-30$7.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001558370-24-012271.Report this figure6,351Current liabilities, Q3 FY2024, at 2024-09-30$6.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure6,268Current liabilities, FY2024, at 2024-12-31$6.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001493152-26-013669.Report this figure663Current liabilities, Q1 FY2025, at 2025-03-31$663.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure760Current liabilities, Q2 FY2025, at 2025-06-30$760.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure1,002Current liabilities, Q3 FY2025, at 2025-09-30$1.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure1,332Current liabilities, FY2025, at 2025-12-31$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure796Current liabilities, Q1 FY2026, at 2026-03-31$796.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure692Current liabilities, Q2 FY2026, at 2026-06-30$692.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure
Total liabilities$k8,198Total liabilities, FY2023, at 2023-12-31$8.2m. XBRL concept us-gaap:Liabilities. 10-K/A filed 2025-11-26, accession 0001493152-25-025179.Report this figurenot reported8,371Total liabilities, Q1 FY2024, at 2024-03-31$8.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001558370-24-008159.Report this figure7,191Total liabilities, Q2 FY2024, at 2024-06-30$7.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001558370-24-012271.Report this figure6,351Total liabilities, Q3 FY2024, at 2024-09-30$6.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001558370-24-015349.Report this figure6,268Total liabilities, FY2024, at 2024-12-31$6.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001493152-26-013669.Report this figure672Total liabilities, Q1 FY2025, at 2025-03-31$672.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure770Total liabilities, Q2 FY2025, at 2025-06-30$770.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001641172-25-023648.Report this figure1,062Total liabilities, Q3 FY2025, at 2025-09-30$1.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure1,343Total liabilities, FY2025, at 2025-12-31$1.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure804Total liabilities, Q1 FY2026, at 2026-03-31$804.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure694Total liabilities, Q2 FY2026, at 2026-06-30$694.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure
Shareholders' equity$k607Shareholders' equity, FY2023, at 2023-12-31$607.0k. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001493152-26-013669.Report this figurenot reported(2,206)Shareholders' equity, Q1 FY2024, at 2024-03-31−$2.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure999Shareholders' equity, Q2 FY2024, at 2024-06-30$999.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure(970)Shareholders' equity, Q3 FY2024, at 2024-09-30−$970.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure(2,174)Shareholders' equity, FY2024, at 2024-12-31−$2.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure3,062Shareholders' equity, Q1 FY2025, at 2025-03-31$3.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure3,631Shareholders' equity, Q2 FY2025, at 2025-06-30$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure7,096Shareholders' equity, Q3 FY2025, at 2025-09-30$7.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure6,842Shareholders' equity, FY2025, at 2025-12-31$6.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure6,760Shareholders' equity, Q1 FY2026, at 2026-03-31$6.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure7,160Shareholders' equity, Q2 FY2026, at 2026-06-30$7.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure

Cash flow

Operating cash flow−$352.0k, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Bio Green Med Solution, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(4,036)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001558370-24-015349. Derived: 9-month figure less the 6-month figure.Report this figure(3,910)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2025-11-26, accession 0001493152-25-025179. Derived: 12-month figure less the 9-month figure.Report this figure(483)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$483.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001641172-25-010270.Report this figure(3,084)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001641172-25-023648. Derived: 6-month figure less the 3-month figure.Report this figure(3,067)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022388. Derived: 9-month figure less the 6-month figure.Report this figure(1,356)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figure(3,247)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure(1,056)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001493152-26-038393. Derived: 6-month figure less the 3-month figure.Report this figure(434)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$434.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022388. Derived: 9-month figure less the 6-month figure.Report this figure(33.0)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$33.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001493152-26-013669. Derived: 12-month figure less the 9-month figure.Report this figure(278)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$278.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure(352)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$352.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001493152-26-038393. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001558370-24-015349. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K/A filed 2025-11-26, accession 0001493152-25-025179. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001558370-24-015349. Derived: 9-month figure less the 6-month figure.Report this figurenot reportednot reportednot reportednot reportednot reported1.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001493152-26-038393. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)5.60m, Q2 FY2026
Bio Green Med Solution, Inc., shares, quarterly
Line itemUnitQ3 FY20212021-09-30Q1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares9.4Diluted shares (weighted), Q3 FY2021, three months to 2021-09-309,368,056 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-11-10, accession 0001558370-22-017410.Report this figure10.0Diluted shares (weighted), Q1 FY2022, three months to 2022-03-319,993,135 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-11, accession 0001558370-23-009443.Report this figure10.1Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3010,136,089 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-10, accession 0001558370-23-014533.Report this figure12.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3012,314,679 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-11-10, accession 0001558370-22-017410.Report this figure12.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3112,539,189 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-11, accession 0001558370-23-009443.Report this figure12.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3012,551,794 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-10, accession 0001558370-23-014533.Report this figure0.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3044,681 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure0.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31365,231 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure1.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,360,626 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure1.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,912,495 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022388.Report this figure5.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-315,458,564 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001493152-26-023800.Report this figure5.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-305,598,701 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure

Shares outstanding: 6.62mShares outstanding, period not labelled, at 2026-08-116,622,794 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001493152-26-038393.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.